Lysosomal Storage Disease (LSD) Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: L2FA50A6AF0AEN
Market Monitor Global

Abstracts

Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder. Further Lipid Metabolism Disorder is categorized into Gaucher disease & Fabry disease and Glycoprotein Metabolism Disorder into Pompe disease. LSD develops mainly due to deficiency of lysosomal enzyme in the living body. A person suffering from LSD could experience problems like abnormal growth of bones, delay movement of body, deafness, blindness, dementia, respiratory problems, fatigue/weakness, bone & joint deformity, organ enlargement, lung dysfunction, severe & fatal physical & mental health deterioration.

This report contains market size and forecasts of Lysosomal Storage Disease (LSD) in Global, including the following market information:

Global Lysosomal Storage Disease (LSD) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lysosomal Storage Disease (LSD) market was valued at 7651.9 million in 2021 and is projected to reach US$ 10550 million by 2028, at a CAGR of 4.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lipid Metabolism Disorder Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lysosomal Storage Disease (LSD) include Actelion Pharmaceuticals, Amicus Therapeutics, Arena Pharmaceuticals, Astellas Pharma, Astrazeneca, Biomarin Pharmaceutical, Eli Lilly, Lexicon Pharmaceuticals and Novo Nordisk and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lysosomal Storage Disease (LSD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lysosomal Storage Disease (LSD) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lysosomal Storage Disease (LSD) Market Segment Percentages, by Type, 2021 (%)

• Lipid Metabolism Disorder
• Glycoprotein Metabolism Disorder

Global Lysosomal Storage Disease (LSD) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lysosomal Storage Disease (LSD) Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Lysosomal Storage Disease (LSD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lysosomal Storage Disease (LSD) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lysosomal Storage Disease (LSD) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lysosomal Storage Disease (LSD) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Actelion Pharmaceuticals
• Amicus Therapeutics
• Arena Pharmaceuticals
• Astellas Pharma
• Astrazeneca
• Biomarin Pharmaceutical
• Eli Lilly
• Lexicon Pharmaceuticals
• Novo Nordisk
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lysosomal Storage Disease (LSD) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lysosomal Storage Disease (LSD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LYSOSOMAL STORAGE DISEASE (LSD) OVERALL MARKET SIZE

2.1 Global Lysosomal Storage Disease (LSD) Market Size: 2021 VS 2028
2.2 Global Lysosomal Storage Disease (LSD) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lysosomal Storage Disease (LSD) Players in Global Market
3.2 Top Global Lysosomal Storage Disease (LSD) Companies Ranked by Revenue
3.3 Global Lysosomal Storage Disease (LSD) Revenue by Companies
3.4 Top 3 and Top 5 Lysosomal Storage Disease (LSD) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lysosomal Storage Disease (LSD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lysosomal Storage Disease (LSD) Players in Global Market
  3.6.1 List of Global Tier 1 Lysosomal Storage Disease (LSD) Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lysosomal Storage Disease (LSD) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lysosomal Storage Disease (LSD) Market Size Markets, 2021 & 2028
  4.1.2 Lipid Metabolism Disorder
  4.1.3 Glycoprotein Metabolism Disorder
4.2 By Type - Global Lysosomal Storage Disease (LSD) Revenue & Forecasts
  4.2.1 By Type - Global Lysosomal Storage Disease (LSD) Revenue, 2017-2022
  4.2.2 By Type - Global Lysosomal Storage Disease (LSD) Revenue, 2023-2028
  4.2.3 By Type - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lysosomal Storage Disease (LSD) Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Lysosomal Storage Disease (LSD) Revenue & Forecasts
  5.2.1 By Application - Global Lysosomal Storage Disease (LSD) Revenue, 2017-2022
  5.2.2 By Application - Global Lysosomal Storage Disease (LSD) Revenue, 2023-2028
  5.2.3 By Application - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lysosomal Storage Disease (LSD) Market Size, 2021 & 2028
6.2 By Region - Global Lysosomal Storage Disease (LSD) Revenue & Forecasts
  6.2.1 By Region - Global Lysosomal Storage Disease (LSD) Revenue, 2017-2022
  6.2.2 By Region - Global Lysosomal Storage Disease (LSD) Revenue, 2023-2028
  6.2.3 By Region - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lysosomal Storage Disease (LSD) Revenue, 2017-2028
  6.3.2 US Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.3.3 Canada Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.3.4 Mexico Lysosomal Storage Disease (LSD) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lysosomal Storage Disease (LSD) Revenue, 2017-2028
  6.4.2 Germany Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.4.3 France Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.4.4 U.K. Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.4.5 Italy Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.4.6 Russia Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.4.7 Nordic Countries Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.4.8 Benelux Lysosomal Storage Disease (LSD) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lysosomal Storage Disease (LSD) Revenue, 2017-2028
  6.5.2 China Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.5.3 Japan Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.5.4 South Korea Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.5.5 Southeast Asia Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.5.6 India Lysosomal Storage Disease (LSD) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lysosomal Storage Disease (LSD) Revenue, 2017-2028
  6.6.2 Brazil Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.6.3 Argentina Lysosomal Storage Disease (LSD) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lysosomal Storage Disease (LSD) Revenue, 2017-2028
  6.7.2 Turkey Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.7.3 Israel Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.7.4 Saudi Arabia Lysosomal Storage Disease (LSD) Market Size, 2017-2028
  6.7.5 UAE Lysosomal Storage Disease (LSD) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Actelion Pharmaceuticals
  7.1.1 Actelion Pharmaceuticals Corporate Summary
  7.1.2 Actelion Pharmaceuticals Business Overview
  7.1.3 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Major Product Offerings
  7.1.4 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue in Global Market (2017-2022)
  7.1.5 Actelion Pharmaceuticals Key News
7.2 Amicus Therapeutics
  7.2.1 Amicus Therapeutics Corporate Summary
  7.2.2 Amicus Therapeutics Business Overview
  7.2.3 Amicus Therapeutics Lysosomal Storage Disease (LSD) Major Product Offerings
  7.2.4 Amicus Therapeutics Lysosomal Storage Disease (LSD) Revenue in Global Market (2017-2022)
  7.2.5 Amicus Therapeutics Key News
7.3 Arena Pharmaceuticals
  7.3.1 Arena Pharmaceuticals Corporate Summary
  7.3.2 Arena Pharmaceuticals Business Overview
  7.3.3 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Major Product Offerings
  7.3.4 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue in Global Market (2017-2022)
  7.3.5 Arena Pharmaceuticals Key News
7.4 Astellas Pharma
  7.4.1 Astellas Pharma Corporate Summary
  7.4.2 Astellas Pharma Business Overview
  7.4.3 Astellas Pharma Lysosomal Storage Disease (LSD) Major Product Offerings
  7.4.4 Astellas Pharma Lysosomal Storage Disease (LSD) Revenue in Global Market (2017-2022)
  7.4.5 Astellas Pharma Key News
7.5 Astrazeneca
  7.5.1 Astrazeneca Corporate Summary
  7.5.2 Astrazeneca Business Overview
  7.5.3 Astrazeneca Lysosomal Storage Disease (LSD) Major Product Offerings
  7.5.4 Astrazeneca Lysosomal Storage Disease (LSD) Revenue in Global Market (2017-2022)
  7.5.5 Astrazeneca Key News
7.6 Biomarin Pharmaceutical
  7.6.1 Biomarin Pharmaceutical Corporate Summary
  7.6.2 Biomarin Pharmaceutical Business Overview
  7.6.3 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Major Product Offerings
  7.6.4 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Revenue in Global Market (2017-2022)
  7.6.5 Biomarin Pharmaceutical Key News
7.7 Eli Lilly
  7.7.1 Eli Lilly Corporate Summary
  7.7.2 Eli Lilly Business Overview
  7.7.3 Eli Lilly Lysosomal Storage Disease (LSD) Major Product Offerings
  7.7.4 Eli Lilly Lysosomal Storage Disease (LSD) Revenue in Global Market (2017-2022)
  7.7.5 Eli Lilly Key News
7.8 Lexicon Pharmaceuticals
  7.8.1 Lexicon Pharmaceuticals Corporate Summary
  7.8.2 Lexicon Pharmaceuticals Business Overview
  7.8.3 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Major Product Offerings
  7.8.4 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue in Global Market (2017-2022)
  7.8.5 Lexicon Pharmaceuticals Key News
7.9 Novo Nordisk
  7.9.1 Novo Nordisk Corporate Summary
  7.9.2 Novo Nordisk Business Overview
  7.9.3 Novo Nordisk Lysosomal Storage Disease (LSD) Major Product Offerings
  7.9.4 Novo Nordisk Lysosomal Storage Disease (LSD) Revenue in Global Market (2017-2022)
  7.9.5 Novo Nordisk Key News
7.10 Merck
  7.10.1 Merck Corporate Summary
  7.10.2 Merck Business Overview
  7.10.3 Merck Lysosomal Storage Disease (LSD) Major Product Offerings
  7.10.4 Merck Lysosomal Storage Disease (LSD) Revenue in Global Market (2017-2022)
  7.10.5 Merck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lysosomal Storage Disease (LSD) Market Opportunities & Trends in Global Market
Table 2. Lysosomal Storage Disease (LSD) Market Drivers in Global Market
Table 3. Lysosomal Storage Disease (LSD) Market Restraints in Global Market
Table 4. Key Players of Lysosomal Storage Disease (LSD) in Global Market
Table 5. Top Lysosomal Storage Disease (LSD) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lysosomal Storage Disease (LSD) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lysosomal Storage Disease (LSD) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lysosomal Storage Disease (LSD) Product Type
Table 9. List of Global Tier 1 Lysosomal Storage Disease (LSD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lysosomal Storage Disease (LSD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lysosomal Storage Disease (LSD) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lysosomal Storage Disease (LSD) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lysosomal Storage Disease (LSD) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lysosomal Storage Disease (LSD) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lysosomal Storage Disease (LSD) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lysosomal Storage Disease (LSD) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2023-2028
Table 30. Actelion Pharmaceuticals Corporate Summary
Table 31. Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Product Offerings
Table 32. Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue (US$, Mn), (2017-2022)
Table 33. Amicus Therapeutics Corporate Summary
Table 34. Amicus Therapeutics Lysosomal Storage Disease (LSD) Product Offerings
Table 35. Amicus Therapeutics Lysosomal Storage Disease (LSD) Revenue (US$, Mn), (2017-2022)
Table 36. Arena Pharmaceuticals Corporate Summary
Table 37. Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Product Offerings
Table 38. Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue (US$, Mn), (2017-2022)
Table 39. Astellas Pharma Corporate Summary
Table 40. Astellas Pharma Lysosomal Storage Disease (LSD) Product Offerings
Table 41. Astellas Pharma Lysosomal Storage Disease (LSD) Revenue (US$, Mn), (2017-2022)
Table 42. Astrazeneca Corporate Summary
Table 43. Astrazeneca Lysosomal Storage Disease (LSD) Product Offerings
Table 44. Astrazeneca Lysosomal Storage Disease (LSD) Revenue (US$, Mn), (2017-2022)
Table 45. Biomarin Pharmaceutical Corporate Summary
Table 46. Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Product Offerings
Table 47. Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly Corporate Summary
Table 49. Eli Lilly Lysosomal Storage Disease (LSD) Product Offerings
Table 50. Eli Lilly Lysosomal Storage Disease (LSD) Revenue (US$, Mn), (2017-2022)
Table 51. Lexicon Pharmaceuticals Corporate Summary
Table 52. Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Product Offerings
Table 53. Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue (US$, Mn), (2017-2022)
Table 54. Novo Nordisk Corporate Summary
Table 55. Novo Nordisk Lysosomal Storage Disease (LSD) Product Offerings
Table 56. Novo Nordisk Lysosomal Storage Disease (LSD) Revenue (US$, Mn), (2017-2022)
Table 57. Merck Corporate Summary
Table 58. Merck Lysosomal Storage Disease (LSD) Product Offerings
Table 59. Merck Lysosomal Storage Disease (LSD) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lysosomal Storage Disease (LSD) Segment by Type in 2021
Figure 2. Lysosomal Storage Disease (LSD) Segment by Application in 2021
Figure 3. Global Lysosomal Storage Disease (LSD) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lysosomal Storage Disease (LSD) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lysosomal Storage Disease (LSD) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lysosomal Storage Disease (LSD) Revenue in 2021
Figure 8. By Type - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028
Figure 12. US Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028
Figure 16. Germany Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 17. France Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028
Figure 24. China Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 28. India Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028
Figure 30. Brazil Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lysosomal Storage Disease (LSD) Revenue Market Share, 2017-2028
Figure 33. Turkey Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lysosomal Storage Disease (LSD) Revenue, (US$, Mn), 2017-2028
Figure 37. Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amicus Therapeutics Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Astellas Pharma Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Astrazeneca Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novo Nordisk Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck Lysosomal Storage Disease (LSD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)